Do rapid detection & isolation of colonised patients reduce Methicillin-Resistant Staphylococcus Aureus (MRSA) spread? An epidemiological, economic & modelling study.

Recruiting

• Conditions: osocomial acquisition of MRSA; Nosocomial acquisition of MRSA; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12607000322437
• Lead Sponsor: Caroline Marshall

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-06-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

All patients admitted to the Royal Melbourne Hospital (adult) IC

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acquisition of MRSA at any time during ICU admission. Patients will required documented evidence of negative screening swabs and then subsequent MRSA positive screening swabs or clinical isolates to be defined as an MRSA acquisition.[Results of swabs will be monitored daily.]

Secondary Outcome Measures

Name	Time	Method
Proportion of patients with new clinical isolate of MRSA.[At any time during ICU admission and for 48 hours after ICU discharge.];Results of swabs.[Will be monitored daily];Patients who have had MRSA colonisation in the ICU.[Will be monitored for development of clinical infection up to the time of hospital discharge]